This post was originally published on this site

CME Group Inc. (NASDAQ:CME) – Equities researchers at Piper Sandler lifted their Q2 2021 earnings per share (EPS) estimates for shares of CME Group in a research report issued to clients and investors on Wednesday, February 10th. Piper Sandler analyst R. Repetto now forecasts that the financial services provider will post earnings per share of $1.68 for the quarter, up from their prior forecast of $1.67. Piper Sandler also issued estimates for CME Group’s Q3 2021 earnings at $1.73 EPS, FY2021 earnings at $6.75 EPS, Q3 2022 earnings at $1.83 EPS and FY2022 earnings at $7.28 EPS.

Several other analysts have also commented on CME. JPMorgan Chase & Co. raised CME Group from an “underweight” rating to a “neutral” rating and raised their target price for the stock from $138.00 to $203.00 in a report on Thursday, January 7th. Rosenblatt Securities dropped their target price on CME Group from $140.00 to $135.00 and set a “sell” rating on the stock in a report on Wednesday, January 6th. Oppenheimer lowered CME Group from an “outperform” rating to a “market perform” rating in a report on Friday, January 15th. They noted that the move was a valuation call. Zacks Investment Research lowered CME Group from a “buy” rating to a “hold” rating and set a $205.00 target price on the stock. in a report on Thursday, January 7th. Finally, Barclays raised their target price on CME Group from $200.00 to $215.00 and gave the stock an “overweight” rating in a report on Tuesday, January 12th. Three equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and five have given a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $187.59.

Shares of NASDAQ:CME opened at $184.37 on Monday. CME Group has a 52-week low of $131.80 and a 52-week high of $225.36. The stock has a market cap of $66.19 billion, a price-to-earnings ratio of 30.73 and a beta of 0.46. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The business has a 50-day moving average price of $187.90 and a 200-day moving average price of $173.90.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Tuesday, February 9th. The financial services provider reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.03. CME Group had a return on equity of 9.22% and a net margin of 43.68%. The firm had revenue of $1.10 billion during the quarter, compared to analysts’ expectations of $1.10 billion. During the same period last year, the business posted $1.52 earnings per share. The company’s revenue for the quarter was down 3.5% compared to the same quarter last year.

Hedge funds have recently bought and sold shares of the stock. Tarbox Family Office Inc. raised its holdings in shares of CME Group by 75.5% in the 3rd quarter. Tarbox Family Office Inc. now owns 193 shares of the financial services provider’s stock valued at $32,000 after buying an additional 83 shares during the period. Rockbridge Investment Management LCC grew its stake in CME Group by 1,663.6% during the 3rd quarter. Rockbridge Investment Management LCC now owns 194 shares of the financial services provider’s stock worth $32,000 after purchasing an additional 183 shares in the last quarter. Paces Ferry Wealth Advisors LLC acquired a new position in CME Group during the 3rd quarter worth $33,000. HHM Wealth Advisors LLC grew its stake in CME Group by 624.0% during the 4th quarter. HHM Wealth Advisors LLC now owns 181 shares of the financial services provider’s stock worth $33,000 after purchasing an additional 156 shares in the last quarter. Finally, TCTC Holdings LLC acquired a new position in CME Group during the 4th quarter worth $33,000. Hedge funds and other institutional investors own 83.88% of the company’s stock.

In related news, insider Hilda Harris Piell sold 2,300 shares of the business’s stock in a transaction on Monday, December 21st. The stock was sold at an average price of $182.00, for a total value of $418,600.00. Following the sale, the insider now owns 39,704 shares in the company, valued at approximately $7,226,128. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Julie Winkler sold 4,059 shares of the business’s stock in a transaction on Monday, December 14th. The shares were sold at an average price of $181.02, for a total value of $734,760.18. Following the completion of the sale, the insider now owns 24,921 shares in the company, valued at approximately $4,511,199.42. The disclosure for this sale can be found here. Insiders sold 12,559 shares of company stock worth $2,267,616 in the last 90 days. Company insiders own 1.20% of the company’s stock.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 25th. Shareholders of record on Wednesday, March 10th will be given a $0.90 dividend. The ex-dividend date of this dividend is Tuesday, March 9th. This represents a $3.60 dividend on an annualized basis and a yield of 1.95%. This is an increase from CME Group’s previous quarterly dividend of $0.85. CME Group’s payout ratio is currently 50.00%.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products through its electronic trading platforms, open outcry, and privately negotiated transactions.

See Also: What is a resistance level?

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.